Insider Transactions in Q1 2019 at Johnson & Johnson (JNJ)
Insider Transaction List (Q1 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 08
2019
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
8,529
+10.56%
|
-
|
|
Feb 08
2019
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,133
-1.66%
|
$281,556
$132.0 P/Share
|
|
Feb 08
2019
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,309
+3.97%
|
-
|
|
Feb 08
2019
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,373
-5.9%
|
$313,236
$132.0 P/Share
|
|
Feb 08
2019
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,882
+12.77%
|
-
|
|
Feb 08
2019
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,033
-2.44%
|
$268,356
$132.0 P/Share
|
|
Feb 08
2019
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,044
+5.7%
|
-
|
|
Feb 08
2019
|
Joseph J Wolk Exec VP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
737
-6.02%
|
$97,284
$132.0 P/Share
|
|
Feb 08
2019
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,540
+17.19%
|
-
|
|
Feb 08
2019
|
Ronald A Kapusta Controller, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
733
-4.55%
|
$96,756
$132.0 P/Share
|
|
Feb 08
2019
|
Ronald A Kapusta Controller, CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,484
+13.35%
|
-
|